Dr. Kumthekar is a UCNS certified neuro-oncologist from Northwestern University dedicated to patient and care and moving the field of brain tumor forward primarily through her leadership on clinical trials. She is currently involved in and lead many clinical trials including being the overall principal investigator of five investigator-initiated treatment trials, including two trials in recurrent meningioma.  She has also served as the principal investigator (PI) of over a dozen additional collaborative brain tumor treatment trials and has served as the study chair/overall PI for multiple multicenter clinical trials. Dr. Kumthekar has also been actively involved in the NCI funded clinical trials for many years. Within the NCTN (National Clinical Trials Network) and serves in leadership roles, particularly with the Alliance for Clinical Trials (Alliance”) for several years and was appointed as the national Executive Officer of Neuro-Oncology at the Alliance in 2016. Dr. Kumthekar has teamed with various scientists both at Northwestern and at other institutions with the goal of using translational research to advance the field.  These partnerships allow for cutting edge scientific discoveries to be successfully brought to the clinic for brain tumor patients to benefit.